Literature DB >> 31911772

IgG4-Producing MALT Lymphoma in the Renal Hilum.

Kota Shimokihara1, Takashi Kawahara2, Ryo Kasahara1, Jun Kasuga1, Shinpei Sugiura1, Ryosuke Tajiri3, Hiroji Uemura2, Kimio Chiba1.   

Abstract

IgG4-related disease is diagnosed when both the elevation of the serum IgG4 level and invasion of IgG4-positive interstitial cells and sclerosis to a tumor are noted. Some cases have demonstrated malignant disease. In the head and neck lesion in particular, IgG4-producing mucosa-associated lymphoid tissue (MALT) lymphoma has arisen during the treatment of IgG4-related disease. We herein report the first case of IgG4-producing MALT lymphoma during the treatment of IgG4-related disease in the renal hilum. A 79-year-old man was being followed for autoimmune pancreatitis and IgG4-related sclerosing cholangitis. During follow-up, magnetic resonance cholangiopancreatography detected a mass in the renal hilum, so he was referred to our department for a further examination. Positron emission tomography-computed tomography detected a standard uptake of 9.7, and the tumor size was gradually increasing. Due to these findings, laparoscopic nephro-ureterectomy was performed. A pathological examination revealed IgG4-producing marginal zone B cell lymphoma. We herein report a rare case of IgG4-producing B cell lymphoma in the renal hilum.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  B cell lymphoma; IgG4-producing B cell lymphoma; IgG4-related disease

Year:  2019        PMID: 31911772      PMCID: PMC6940442          DOI: 10.1159/000504699

Source DB:  PubMed          Journal:  Case Rep Oncol        ISSN: 1662-6575


  6 in total

1.  Low-grade mucosa-associated lymphoid tissue lymphoma involving the kidney: report of 3 cases and review of the literature.

Authors:  Libo Qiu; Pamela D Unger; Robert W Dillon; James A Strauchen
Journal:  Arch Pathol Lab Med       Date:  2006-01       Impact factor: 5.534

2.  The value of 18F-FDG PET/CT in the distinction between retroperitoneal fibrosis and its malignant mimics.

Authors:  Yiwen Wang; Zhiwei Guan; Dai Gao; Gui Luo; Kunpeng Li; Yurong Zhao; Xiuru Wang; Jie Zhang; Jingyu Jin; Zheng Zhao; Chunhua Yang; Jianglin Zhang; Jian Zhu; Feng Huang
Journal:  Semin Arthritis Rheum       Date:  2017-08-03       Impact factor: 5.532

3.  Immunoglobulin G4 (IgG4)-Positive Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma and Idiopathic Orbital Inflammation.

Authors:  Eun Jung Sohn; Hee Bae Ahn; Mee Sook Roh; Woo Jun Jung; Won Yeol Ryu; Yoon Hyung Kwon
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2018 Jul/Aug       Impact factor: 1.746

4.  Risk of malignancies in IgG4-related disease.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Tetsuya Tabeya; Chisako Suzuki; Yasuyoshi Naishiro; Keisuke Ishigami; Hidetaka Yajima; Yui Shimizu; Mikiko Obara; Hiroyuki Yamamoto; Tetsuo Himi; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Mod Rheumatol       Date:  2011-09-06       Impact factor: 3.023

5.  Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease.

Authors:  Wah Cheuk; Hunter K L Yuen; Alexander C L Chan; Lee-Yung Shih; Tseng-Tong Kuo; Ming-Wai Ma; Yan-Fai Lo; Wai-Kong Chan; John K C Chan
Journal:  Am J Surg Pathol       Date:  2008-08       Impact factor: 6.394

6.  IgG4-producing lymphoma arising in a patient with IgG4-related disease.

Authors:  Takuro Igawa; Toshiaki Hayashi; Kazuya Ishiguro; Yumiko Maruyama; Mai Takeuchi; Katsuyoshi Takata; Tadashi Yoshino; Yasuharu Sato
Journal:  Med Mol Morphol       Date:  2016-04-11       Impact factor: 2.309

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.